Total Credits: 1.0 including 1 AOA Category 1-A Credit(s)
The opioid epidemic is a national crisis. Dr. Kevin O'Donnell presents a non-opioid approach to the treatment of pain and musculoskeletal disorders.
Learning objectives:
1. Mitigate the ramifications of the opioid epidemic
2. Demonstrate safe approaches to opioid prescribing
3. Identify and employ adjunctives to pain and MSK disorders
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the American Osteopathic Association (AOA). The Arizona Osteopathic Medical Association (AOMA) is accredited by the American Osteopathic Association (AOA) to provide osteopathic continuing medical education for physicians.
GRIEVANCE POLICY: The AOMA strives to provide continuing medical education programs to fulfill the needs of the attendees and to meet the AOA Uniform Guidelines and AOA Accreditation Requirements. Comments, questions, or complaints should be forwarded to AOMA Executive Director Josephine Zammuto, by calling the AOMA Office at 602-266-6699 or by mail to AOMA, 5150 N. 16th Street, Suite A-122, Phoenix, AZ 85016, or by email to info@az-osteo.org.
Non Opioid Pain and MSK.pdf (3.00 MB) | 47 Pages | Available after Purchase |
Kevin O’Donnell, DO is an expert in the field of non-surgical musculoskeletal care and ultrasound-guided regenerative therapies such as stem cell therapy, platelet-rich plasma,and prolotherapy. He also specializes in minimally invasive treatments for osteoarthritis and chronic soft tissue injuries. Dr. O’Donnell completed his medical school at Philadelphia College of Osteopathic Medicine and his residency training at Lehigh Valley Hospital in Allentown, Pennsylvania. After residency, Dr. O’Donnell completed specialty orthopedic training at ProMedica in Toledo, Ohio, in the form of a primary care sports medicine fellowship. He is active in caring for local high school, college, and national and international professional athletes.
Dr. O'Donnell has not disclosures.
5 |
|
4 |
|
3 |
|
2 |
|
1 |
|